Malcolm Nowlin is a Business Analyst at BioMotiv and a fellow with Venture for America, a fellowship that connects recent college graduates with startups in United States cities with emerging entrepreneurial ecosystems. Before BioMotiv, Malcolm worked in the Public Policy and Regulatory Affairs division of Aetna. Prior to that, he led a team that gathered and analyzed data on emerging infectious disease drug development with Global Healthcare Innovation Alliances Accelerator (G.H.I.A.A) in collaboration with the World Health Organization.
Malcolm graduated from Duke University with a B.A. in Public Policy Analysis and a minor in Chemistry.